Clinical implications of genetic polymorphisms in blepharospasm.
blepharospasm
botulinum neurotoxin
gene
genotype analysis
polymorphism
Journal
Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
received:
23
11
2023
accepted:
14
05
2024
medline:
9
7
2024
pubmed:
9
7
2024
entrez:
9
7
2024
Statut:
epublish
Résumé
The possible genetic variants associated with blepharospasm (BSP) and facial dystonia have been investigated. Although genetic variants associated with BSP have been extensively studied, the contribution of single-nucleotide polymorphisms towards this condition remains poorly understood. In addition, the etiology of BSP remains to be fully elucidated. Therefore, the present study aimed to assess the role of polymorphisms in the torsin 1A (TOR1A), dopamine receptor D (DRD)2 and DRD5 genes in South Korean patients with BSP. Furthermore, the role of genetic variants of these three aforementioned genes was investigated. A prospective case-control study was established, where 56 patients with BSP and 115 healthy controls were recruited at the Department of Ophthalmology of CHA Bundang Medical Center (Seongnam, South Korea) using single nucleotide polymorphisms analysis by real-time PCR. The
Identifiants
pubmed: 38979016
doi: 10.3892/etm.2024.12621
pii: ETM-28-2-12621
pmc: PMC11228564
doi:
Types de publication
Journal Article
Langues
eng
Pagination
332Informations de copyright
Copyright: © 2024 Jang et al.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.